This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Globus Medical pulled, refiled FTC premerger notification paperwork for NuVasive acquisition, US SEC filing says

( April 3, 2023, 21:46 GMT | Official Statement) -- Medical device manufacturer Globus Medical pulled and refiled its premerger notification form for its purchase of spine device maker NuVasive with the US Federal Trade Commission on Friday, according to a filing NuVasive submitted to the US Securities and Exchange Commission. Globus Medical's pull-and-refile triggered the onset of a new 30-day waiting period for its deal with NuVasive, which will conclude after May 3.* The merging parties "continue to expect that the proposed transaction will close in the middle of 2023," according to NuVasive's SEC filing. *Corrected April 4, 2023, at 19:10 GMT; corrects the conclusion date for the 30-day waiting period.See SEC filing excerpt below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login